Potential break-throughs in the making
BCR ABL1 inhibitor for treating Chronic Myeloid Leukemia
Anti-MUC-1 ADC for treatment of solid tumours
S1PR1 agonist for treating auto-immune disorders
Topical drug for treatment of Alopecia Areata
